bg
A

Adaptimmune - ADR (ADAP)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Adaptimmune - ADR (ADAP)

Adaptimmune Therapeutics plc is a clinical-stage biopharmaceutical company. The Company is focused on cancer immunotherapy products based on its Specific Peptide Enhanced Affinity Receptor (SPEAR) T-cell platform. Its SPEAR T-cell platform enables it... Read more

  • USD1.65
  • USD1.65
  • USD1.53
  • USD2.05
  • -7.60%
  • 48M
  • 1.07M
  • 2.02M
  • 355M
  • 0.42
  • 43.60%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.